Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Net Sales	$ 5,997.8	$ 4,673.3	$ 4,623.4
Cost of products sold, excluding intangible asset amortization	1,800.6	1,242.8	1,266.7
Intangible asset amortization	337.4	92.5	78.5
Research and development	268.8	187.4	203.0
Selling, general and administrative	2,284.2	1,750.7	1,749.3
Certain claims (Note 20)	7.7	21.5	47.0
Special items (Note 3)	831.8	341.1	210.3
Operating expenses	5,530.5	3,636.0	3,554.8
Operating Profit	467.3	1,037.3	1,068.6
Other expense, net	(36.9)	(46.7)	(6.0)
Interest income	9.4	11.9	15.6
Interest expense	(286.6)	(63.1)	(70.1)
Earnings before income taxes	153.2	939.4	1,008.1
Provision for income taxes	7.0	220.2	229.5
Net earnings	146.2	719.2	778.6
Less: Net loss attributable to noncontrolling interest	(0.8)	(1.1)	(1.8)
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 147.0	$ 720.3	$ 780.4
Earnings Per Common Share - Basic	$ 0.78	$ 4.26	$ 4.60
Earnings Per Common Share - Diluted	$ 0.77	$ 4.20	$ 4.54
Weighted Average Common Shares Outstanding
Basic	187.4	169.0	169.6
Diluted	189.8	171.7	171.8
Cash Dividends Declared Per Common Share	$ 0.88	$ 0.88	$ 0.80